Maze Therapeutics, Inc. (MAZE): Revenue

Annual figures by period end, from SEC filings.

$167.50M

Year ended 2024-12-31

Period ended	Revenue	Change YoY	Source filing
2024-12-31	$167.50M	n/a	2026-03-25, From 2024-01-01